HCA Healthcare price target raised to $320 from $285 at Loop Capital

Loop Capital analyst Joseph France raised the firm’s price target on HCA Healthcare to $320 from $285 and keeps a Buy rating on the shares after its earnings beat. The company reported much better-than-expected Q1 results driven by a strong recovery in admissions, procedures and more normal operating costs, as turnover slowed and hiring accelerated, the analyst tells investors in a research note. The quarter also included a favorable settlement and some Covid relief that Loop Capital did not expect, the firm states, adding that Q1 should also be the toughest comp for the company in 2023.